Prospective Follow-up Study of Patients With Severe Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair M-TEER at Bad Segeberg Heart Center

What this Trial Is About

This research aims to follow patients with severe mitral regurgitation MR who are treated using a procedure called mitral edge-to-edge repair M-TEER. The study is conducted at a single center, the Heart Center in Bad Segeberg, Germany, and focuses on observing patients undergoing this treatment to understand their health outcomes over time. Participants receive the mitral valve transcatheter edge-to-edge repair M-TEER, a device-based procedure designed to address severe MR. The study records data from patients treated with this procedure and follows them through a routine clinical schedule, including long-term follow-up to monitor their condition and treatment effects. Throughout the study, participants undergo regular clinical assessments, with researchers tracking their health status and any cardiovascular adverse events that occur both during hospitalization and over a two-year period. The main outcome measured is the rate of these adverse events. Participants are monitored closely according to the study protocol, which extends over a long-term timeline to gather comprehensive follow-up information.

The Prospective Segeberg Registry for Mitral Transcatheter Edge-to-Edge Repair